Private Equity Outlook with Jim Rosener, Partner, Pepper Hamilton

|Comments are Off
WATCH THE INTERVIEW Leading private equity lawyer, Jim Rosener, discusses the evolution of the private equity industry to where it is today: more than 3,500 funds with more than $1.14 trillion in dry powder, according to Institutional Investor.  The interview also...

November 7, 2019, 1-2PM Pacific Time: Successful Capital Raise – Tips and Strategies from Investment Bankers

|Comments are Off
REGISTER COMPLIMENTARY/ SUBMIT QUESTIONS TO SPEAKERS HERE Join the discussion with two veteran investment bankers on best practices, strategies and common mistakes made in raising debt and equity capital for emerging growth and established companies. We will answer questions from...

Avoiding and Resolving Post-Acquisition Disputes and MAC Clauses Litigation

|Comments are Off
The panel will address potential disputes arising in the context of an M&A transaction focusing the material adverse change (MAC) clauses, which may give the buyer the right to terminate the agreement if the target experiences a material adverse change to the business. The...

Transactions, Valuation and Risk Mitigation in Cannabis “Without Touching the Plant”

|Comments are Off
The booming cannabis industry has created investment and transactional opportunities in many sectors ancillary to the industry which “do not touch the plant directly.” Our panel of experts will discuss investment and transactional opportunities in the Cannabis Ancillary sector,...

Trends and Transactions in Emerging Markets M&A

|Comments are Off
According to market research, almost 3/4 of global M&A deals fail, particularly those in the emerging markets.  Our panel of experts will examine transaction structures, tax implications, due diligence and investigative imperatives, and access to information to plan for both,...

BioPharma M&A: Keys to Success

|Comments are Off
WATCH THIS PROGRAM ON-DEMAND / CLICK HERE FOR COMPLIMENTARY ACCESS Over the first half of 2019, a staggering $170B has been pledged to biopharma buyout activities, an amount that exceeds the total deal spend of the last three years combined. With the increasing complexity and...

Deal Sourcing, Financing and Closing Strategies for Independent Sponsors

|Comments are Off
SPEAKERS: Sylvie Gadant, Transaction Advisory Services Practice Leader, Citrin Cooperman Terry Keating, President and CEO, Accord Financial, Inc. Elaine Carey, Managing Director, Forensic & Litigation Consulting, FTI Consulting Gerry Williams, Partner, DLA Piper, Member, US...

From Thought Leader to Rainmaker: How to Build Authority, Influence and New Business

|Comments are Off
SPEAKERS: Jay Harrington, President and Founder, Harrington Scott Becker, Partner, McGuireWoods, Founder and Publisher, Becker’s Hospital Review and Becker’s Healthcare Anna Spektor, Founder and CMO, Expert Webcast MODERATOR: Alex Kasdan, Senior Managing Director,...

Do’s and Don’ts in the M&A Process

|Comments are Off
The panel comprised of corporate counsel, technology, due diligence and investment banking professionals will address the private company M&A process, from the pre-transaction stage to closing and post-transaction planning, with particular emphasis on deal structuring, due...

Opportunity Zones — Tax Planning for Closely Held Businesses

|Comments are Off
PANEL: Louis Vlahos, Tax Partner, Farrell Fritz, P.C. Craig Bernstein, Principal, OPZ Bernstein Opportunity Zone Fund David Rosen, Partner, Director of Tax Services at RS&F MODERATOR: Alex Kasdan, Senior Managing Director, DelMorgan & Co. The panel will focus on the...